Christina A. Risatti, Ph.D. - Publications

2005 University of Notre Dame, Notre Dame, IN, United States 
polyketide natural products

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Chen K, Risatti C, Eastgate M. Overcoming Electronics with Strategy: Development of an Efficient Synthesis of the HIV Attachment Inhibitor Prodrug, BMS-663068 Strategies and Tactics in Organic Synthesis. 11: 171-233. DOI: 10.1016/B978-0-08-100023-6.00007-5  0.92
2014 Chen K, Risatti C, Bultman M, Soumeillant M, Simpson J, Zheng B, Fanfair D, Mahoney M, Mudryk B, Fox RJ, Hsaio Y, Murugesan S, Conlon DA, Buono FG, Eastgate MD. Synthesis of the 6-azaindole containing HIV-1 attachment inhibitor pro-drug, BMS-663068. The Journal of Organic Chemistry. 79: 8757-67. PMID 25144249 DOI: 10.1021/Jo5016008  0.92
2013 Risatti C, Natalie KJ, Shi Z, Conlon DA. Development of a scalable route to a dual NK-1/serotonin receptor antagonist Organic Process Research and Development. 17: 257-264. DOI: 10.1021/op300323k  0.92
2011 Xu Q, Huang KC, Tendyke K, Marsh J, Liu J, Qiu D, Littlefield BA, Nomoto K, Atasoylu O, Risatti CA, Sperry JB, Smith AB. In vitro and in vivo anticancer activity of (+)-spongistatin 1. Anticancer Research. 31: 2773-9. PMID 21868519  0.92
2011 Smith AB, Risatti CA, Atasoylu O, Bennett CS, Liu J, Cheng H, TenDyke K, Xu Q. Design, synthesis, and biological evaluation of diminutive forms of (+)-spongistatin 1: lessons learned. Journal of the American Chemical Society. 133: 14042-53. PMID 21761891 DOI: 10.1021/Ja2046167  0.92
2010 Smith AB, Risatti CA, Atasoylu O, Bennett CS, Tendyke K, Xu Q. Design, synthesis, and biological evaluation of EF- and ABEF- analogues of (+)-spongistatin 1. Organic Letters. 12: 1792-5. PMID 20297810 DOI: 10.1021/Ol100418N  0.92
2010 Atasoylu O, Furst G, Risatti C, Smith AB. The solution structure of (+)-spongistatin 1 in DMSO Organic Letters. 12: 1788-1791. PMID 20297809 DOI: 10.1021/ol100417d  0.92
2009 Smith AB, Sfouggatakis C, Risatti CA, Sperry JB, Zhu W, Doughty VA, Tomioka T, Gotchev DB, Bennett CS, Sakamoto S, Atasoylu O, Shirakami S, Bauer D, Takeuchi M, Koyanagi J, et al. Spongipyran Synthetic Studies. Evolution of a Scalable Total Synthesis of (+)-Spongistatin 1. Tetrahedron. 65: 6489-6509. PMID 20640040 DOI: 10.1016/J.Tet.2009.04.003  0.92
2008 Smith AB, Tomioka T, Risatti CA, Sperry JB, Sfouggatakis C. Gram-scale synthesis of (+)-spongistatin 1: development of an improved, scalable synthesis of the F-ring subunit, fragment union, and final elaboration. Organic Letters. 10: 4359-62. PMID 18754594 DOI: 10.1021/ol801792k  0.92
2004 Risatti CA, Taylor RE. Enantioselective synthesis of cyclopropanes by aldehyde homologation. Angewandte Chemie (International Ed. in English). 43: 6671-2. PMID 15593156 DOI: 10.1002/Anie.200461106  0.92
2004 Suckow MA, Gutierrez LS, Risatti CA, Wolter WR, Taylor RE, Pollard M, Navari RM, Castellino FJ, Paoni NF. The anti-ischemia agent ranolazine promotes the development of intestinal tumors in APC(Min/+) mice. Cancer Letters. 209: 165-9. PMID 15159018 DOI: 10.1016/J.Canlet.2004.01.007  0.92
2004 Risatti CA, Taylor RE. Biomimetic Synthesis of Polycyclic Natural Products from Acyclic Precursors Chemtracts. 17: 83-91.  0.92
2003 Taylor RE, Risatti CA, Engelhardt FC, Schmitt MJ. Cyclopropane structural units from homoaldol adducts. Organic Letters. 5: 1377-9. PMID 12688763 DOI: 10.1021/Ol034448R  0.92
Show low-probability matches.